microdose semaglutide side effects People are 'microdosing' weight-loss drugs. A GP explains what to watch out for Thinking About Microdosing GLP-1? 5

Estrogen and Fat Distribution Women store fat differently than men, with greater proportions in subcutaneous deposits around the hips, thighs, and breasts

The FDA first approved it as an appetite suppressant in 1959

These receptors normally activate when your intestines detect food, signaling your brain that you are full and satisfied

Efficacy and Safety of the New Appetite Suppressant, Liraglutide: A Meta-Analysis of Randomized Controlled Trials

Key findings included: Not every patient experiences dramatic rebound

The quick answer: Semaglutide is a GLP-1 receptor agonist an injectable (and now oral) drug FDA-approved for long-term, chronic weight management , producing the larger weight loss but at meaningfully higher cost